分子靶向的血管生成显像研究进展
出处
《广东医学》
CAS
CSCD
北大核心
2007年第12期2037-2038,共2页
Guangdong Medical Journal
基金
广东省医学科研基金立项项目(编号:A2006502)
参考文献16
-
1CLAPP C, MARTIAL J A, GUZMAN R C, et al. The 16 -kilodalton N - terminal fragment of human prolactin is a potent inhibitor of angiogenesis[ J ]. Endocrinology, 1993, 133 (3) : 1292 - 1299.
-
2WILSON C B, LAMMERTSMA A A, MCKENZIE C G, et al. Measurements of blood flow and exchanging water space in breast tumors using positrom emission tomography: a rapid and noninvasire dynamic method[J]. Cancer Res, 1992, 52(6) : 1592 - 1597.
-
3HAUBNER R, WESTER H J, BURKHART F, et al, Glycosylated RGD - containing peptides : tracer for tumor targeting and anglogenesis imaging with improved diokinetics [ J ], J Nucl Med, 2001,42(2) : 326 -336.
-
4VAN HAGEN P M, BREEMAN W A, BERNARD H F, et al. Evaluation of a radiolabelled cyclic DTPA - RGD anal ogue for turnout imaging and radionuclide therapy[J]. Int J Cancer, 2000, 90 (4) : 186 - 198.
-
5HAUBNER R, WESTER H J, WEBER W A, et al. Non - containing imagingof av β3 integrin expression using a ^18F - labeled Rgd - containing glycopeptide and positron emission tomogtaphy [ J ]. Cancer Res, 2001,61(5) : 1781 -1785.
-
6CHAN C, SANDHU J, GUHA A, et al, A human transferrinvascular endothelial growth factor (hnTf- VEGF) fusion protein containing an integrated binding site for^111 In for imaging tumor angiogenesis[ J].J Nucl Med, 2005,46(10) : 1745 -1752.
-
7CASTELLANI P, DORCARATTO A, PAU A, et al. The angiogenesis marker ED - B + fibronectin isoform in intraeranial meningiomas [J]. Acta Neurochir, 2000, 142 ( 3 ) : 277 - 282.
-
8NERI D, CARNEMOLLA B, NISSIM A, et al. Targeting by affinity- matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform[J]. Nat Biotechnol, 1997, 15 (12): 1271 -1275.
-
9TARLI L, BALZA E, VITI F, et al. A high-affinity guman antibody that targets tumoral blood vessels[ J]. Blood, 1999, 94( 1 ) : 192 - 198.
-
10FODA H D, ZUCKER S. Matrix metalloproteinases in cancer invasion, metastasis and angiogenesis [ J]. Drug Discov Today, 2001,6(9) : 478 -482.
-
1丽娜.把癌细胞消灭在萌芽中[J].抗癌,2003(4):41-41.
-
2张春峰,刘玉龙,孙立磊.MRI类PET技术对肺癌临床治疗的价值评估[J].中国现代医生,2016,54(2):97-99. 被引量：2
-
3Merrick MV,赵德明.当今的骨闪烁显像[J].国外医学（放射医学核医学分册）,1990,14(3):140-141.
-
4张新睿,邓敬兰,乔宏庆,马兴荣,陈敏.骨转移癌的骨闪烁显像145例分析[J].第四军医大学学报,1994,15(4):319-320.
-
5胡立宽,贾士铨.单抗标记在肿瘤免疫闪烁显像诊治中的应用[J].国外医学（肿瘤学分册）,1989,16(6):323-326.
-
6郑妙闇,鲁士伟,肖连东,王国强,刘耀辰,孙继芝,林庭樽.全身骨闪烁显像探测恶性肿瘤骨转移(附110例分析)[J].中国肿瘤临床,1992,19(4):250-252. 被引量：2
-
7任瑞美,付正,于金明,张永明,张国芬,赵献光.FDG PET-CT在食管癌放疗靶区勾画中的作用[J].中华放射肿瘤学杂志,2009,18(6):429-430. 被引量：6
-
8韩晖,林舜国,许春森,赵文新,陈大良,郑宇辉,杨映红.环氧化酶-2、血管内皮生长因子在乳腺癌组织中表达及其对血管生成的影响[J].中华乳腺病杂志（电子版）,2008,2(6):33-36. 被引量：1
-
9袁惠,王丹,陈红艳,牛锦东.肝细胞性肝癌超声造影定量参数与微血管密度的相关性研究[J].中国临床医学影像杂志,2009,20(4):255-257. 被引量：8
-
10Goldenberg D M,李贵平.展望放射性标记单克隆抗体在肿瘤诊治中的作用[J].国外医学（肿瘤学分册）,1990,17(5):292-293.
